View Author
scopus: 14069150600

Rezaee, F.

(Farhad Rezaee)


plasma fraction gaucher patient disease gaucher patients lipoprotein level phospholipid therapy lipoproteins mip -1β analysis plasma lipoproteins lipoprotein fractions composition protein plasma lipoprotein lipid study figure gaucher disease range mip -1β levels chitotriosidase reports | 1 mip -1α cholesterol idl fraction plasma mip -1β spleen cm fraction result lc-esi-m control gaucher cells 139 | density marrow sample method plasma lipoprotein fractions van breemen bone complications effect vldl fraction plff fraction bone marrow phospholipid composition complication hptlc chromatography density lipoproteins plasma levels / biochimica activity ultracentrifugation 5 years hdl fraction chemokine tandem plasma mip -1α marker retention time window atherosclerosi approach treatment concentration spectrometry ldl fraction ccl 18 panel material macrophage species presence density lipoprotein enzyme plasma chitotriosidase tandem ms




3 Most Recent Publications

Hedgehog signalling as an antagonist of ageing and its associated diseases (Article)
Dashti, M. Peppelenbosch, M.P. Rezaee, F.
2012-10-01
A phospholipidomic analysis of all defined human plasma lipoproteins (Article)
Dashti, M. Kulik, W. Hoek, F. Veerman, E.C. Peppelenbosch, M.P. Rezaee, F.
2011-12-01
Increased plasma macrophage inflammatory protein (MIP)-1α and MIP-1β levels in type 1 Gaucher disease (Article)
Breemen, M.J. van Fost, M. de Voerman, J.S. Laman, J.D. Boot, R.G. Maas, M. Hollak, C.E.M. Aerts, J.M.F.G. Rezaee, F.
2007-07-01